Noble metals: a toxicological appraisal of potential new environmental contaminants. by Brubaker, P E et al.
Environmental Health Perspectives
Vol. 10, pp. 39-56, 1975
Noble Metals: A Toxicological Appraisal of
Potential New Environmental Contaminants
byPaul E. Brubaker,* John P. Moran,* Kenneth Bridbord,* and F. Gordon
Hueter*
The public health benefits expected by reducing known hazardous emissions from mobile
sources should not be compromised by increasing levels of other potentially hazardous
unregulated emissions. Catalytic converters are going to be used to meet the statutory
requirements on carbon monoxide and hydrocarbon emissions from light duty motor
vehicles. Platinum and palladium metals are the catalytic materials to be used in these
emission control devices. Preliminary experimental evidence and analysis of the impact
of these control devices on the future use and demand for platinum indicates that this
metal may appear at detectable levels in the environment by the ena o't this deFade. At
the present time, platinum and palladium are not present in the public environment and
represent potentially new environmental contaminants as a consequence of use of this
new abatement control technology. There is relatively little information available to
adequately assess the potential health hazards that may be associated 'with exposure to
these metals and their compounds. Analysis of the environmental problems and concerns
associated with possible new environmental contaminants are discussed. Limited esti-
mates are made on community exposure by use of a meteorological dispersion model.
Biodegradation potential and attention is also given to the limited toxicological infor-
mation available.
Introduction
Continuing international progress in com-
merce and technology has had a profound
impact on the entire global ecosystem. Air,
water, soil and biota; all compartments of
the environment have been intentionally and
unintentionally contaminated with a wide
variety of toxic substances. The manufac-
ture of many commercial chemicals designed
for use in closed systems as well as those
intended for direct environmental applica-
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tion and regulated by stringent legislative
-controls have been unexpected pollutants that
threaten environnlental vitality. Natural re-
sources have been utilized in many industrial
and commercial applications that modify,
redistribute and concentrate them in a fash-
ion that distorts their equilibrium in the
ecosystem. It is now recognized that such
distortions can pose a threat to public health
and welfare of immediate and future genera-
tions (1,2).
The epidemiology of health adversities
associated with atmospheric contamination
has shown that air pollution alone contrib-
utes to increased mqrtality and morbidity,
aggravates and accelerates the pathogenesis
April 1975 39of chronic respiratory diseases, and may in-
duce a variety of immediate and delayed
systemic pathologies (3-8). National con-
cern has provided a mandate in the amended
Clean Air Act (1970) and the National
Environmental Policy Act of 1970 to estab-
lish standards of environmental quality
which afford protection of public health and
welfare. Establishing and enforcing prudent
standards of environmental quality requires
development and continual refinement of a
broad integrated data base that is sufficiently
quantitative to permit adequate risk-hazard
assessment and reasonable cost-benefit analy-
sis (9). While standard compliance serves as
an impetus for developing new abatement
control technologies of immediate economic
significance on a national scale, it is impor-
tant to recognize public health priorities and
the nature of pollution-induced health adver-
sities that influence national economic policy
on a long-term basis. The National Emissions
Standards Act (Title II of the Amended
Clean Air Act 1970), recognizes exhaust
emissions from motor vehicles threatens
public health in many urban areas (10-15).
In order to guarantee ambient air quality
and assure public health protection, a 90%
reduction in carbon monoxide and hydro-
carbons from 1971 emission levels of light-
duty motor vehicles was scheduled for com-
pliance by 1976. A similar reduction in oxides
of nitrogen from these same mobile sources
was required by 1977. In the absence of
marketable engine designs to achieve these
reductions as scheduled, compliance with
these standards has lead to the development
of an emissions abatement technology that
involves oxidation or reduction catalytic con-
version of these regulated exhaust emissions
(CO, HC, NO.) to carbon dioxide, nitrogen,
oxygen, and water. However, public health
benefits achieved by new abatement tech-
nology should not be compromised by in-
creasing levels of other emissions presently
unregulated or by the introduction of new
environmental contaminants (16).
Assessment of public health hazards asso-
ciated with exposure to existing ambient air
pollutants encompasses epidemiology, atmos-
pheric monitoring, meteorological dispersion
analysis, and aerometric chemistry with
aligned clinical, and experimental toxicology
programs. The integration of these desci-
plines forms the basis of the national Com-
munity Health and Environmental Surveil-
lance System (CHESS) (17). However,
analysis of new substances presents a modi-
fied strategy that requires toxicological
analysis prior to their appearance in ambient
air.
Classical toxicology routinely involves ad-
ministration of graded dosages of a given
substance by various exposure routes to sev-
eral species of adult experimental animals.
The nature of the injury produced is deter-
mined, critical organs are identified and dose-
response curves constructed from acute, sub-
acute, chronic and subchronic exposures in
order to predict toxicity over a limited dos-
age range beyond those determined experi-
mentally. Threshold limit values are time-
weighted exposure limits used in industrial
hygiene to minimize adverse health effects
among employees subjected to daily expo-
sures of various chemicals found in occupa-
tional atmospheres (18). While they should
not be used to distinguish harmful from safe
concentrations, they are based upon informa-
tion derived from previous occupational
health observations, experimental clinical
programs and animal toxicological investiga-
tions. This information, qseful for industrial
hygiene purposes, is only of limited value for
environmental health considerations due in
part to the heterogenity in health of the
general population and abatement program
requirements. Since ambient air pollutants
contaminate several compartments of the
ecosystem, public health considerations and
control programs must also consider their
biotransformation potential and risk-hazard
analysis of alternate exposure routes. For
example, special reference is made to metallic
compounds, particularly methylmercury (19,
20). Furthermore, biotransformation also in-
cludes metabolic modification of inactive
parent compounds that become active upon
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of new ambient air pollutants should not
necessarily be confined to inhalation routes
if absorption and biotransformation are dis-
tinct possibilities.
Adverse health effects may arise from pro-
longed exposure to low levels of environ-
mental agents, intermittent exposure to high
levels, and may also appear as a consequence
of multiple environmental factors acting in
concert. The health effects arising from low
level exposures to hazardous environmental
agents encompasses a continuous and pro-
gressively complex spectrum of subtle physio-
logical anomalies that have an increasing
probability of becoming irreversible/incur-
able upon continuous exposure (21). In gen-
eral, these exposure conditions tend to
amplify pathology in susceptable subgroups
of the population predisposed by age, pre-
existing illness, and genetic insufficiencies
(22-24). The complexity of pollution-induced
disease etiology is considerably reduced due
to manifestation of discernable response
parameters in these individuals. The pollu-
tant-health effect relationship becomes ex-
ceedingly complex in the absence of param-
eters that delineate onset, progression and
termination of stress response. Among
immediate adverse effects that can be ex-
pected in healthy individuals are those aris-
ing from interference in normal defense
mechanisms such as reduced tolerance result-
ing from metabolic and immunological defi-
cits and induction of allergic hypersensitives
(25,26). Moreover, health adversities asso-
ciated with chronic low level exposure condi-
tions often appear among both healthy and
predisposed individuals following prolonged
latent periods. Teratogenic, carcinogenic, and
mutagenic effects are terminal endpoints of
such exposures that appear following latent
periods that range from months to years
and to subsequent generations, respectively
(27-34).
Ambient air pollutants constitute a broad
range of biologically active chemical and
physical agents. The inhalation hazards of
many chemical compounds associated with
automotive exhaust emissions have been
described (6,7). While it is important to
emphasize accuracy in toxicological analysis,
it is of equal importance to stress integration
of protocols (35). Selection of appropriate
experimental animals, use of protocols that
have biological equivalents in epidemiologi-
cal and clinical studies, use of parameters
that serve as exposure indicators as well as
those that may predict impending pathology
provide an important means of linking ex-
perimental observations with environmental
surveillance of community health. Quantita-
tive toxicological analysis and abatement
program effectiveness depends upon adequate
identification of active biological materials.
Those chemicals that have a potential for
wide use, broad distribution, and can attain
hazardous exposure levels should require
toxicological analysis for sufficient assess-
ment of population and exposure hazards.
Evaluation of new compounds should be
completed at an early stage in order to assess
their environmental compatability and to
determine abatement program feasibility.
While the elimination of sulfuric acid aero-
sols and particulate sulfates, a function of
fuel composition, are of immediate concern,
the use of catalytic convertors on light-duty
motor vehicles may represent a source of new
environmental agents of broad distribution
potential, the attrition products of platinum-
group metals. In the absence of sufficient
toxicological information necessary for as-
sessing public health hazards, the purpose of
this report is to address the following prob-
lem areas: analysis of past national consump-
tion and use of noble metals and evaluation
of their potential for future environmental
contamination; review of relevant informa-
tion from reported industrial hygiene experi-
ence; estimation of exposure levels under
various meteorological conditions; Biomedi-
cal aspects of concern, namely, immediate
and delayed hypersensitivity, carcinogenic-
ity, and biotransformation (methylation);
identification of areas of concern regarding
regulation and control.
April 1975 41Table 1. Consumption of platinum group metals and their distribution among major industries in the United States.
1961 1972 Annual average
1961-1972
World production of platinum-group metals
G/yr. 84,989,134.43
Qz troy/yr - 2,732,506.01
Tons/yr 93.62
U. S. consumption of platinum-group metals
G/yr - - 38,862,413.15
Oz troy/yr 1,249,474.73
Tons/yr 43.81
U.S. consumption, % of average annual world production 45.7
U.S. platinum-group metal consumption among major con-
suming industries, %
Electrical 54.2 34.4 43.4
Chemical 20.9 37.8 28.5
Petroleum 4.6 8.1 9.1
Medical 8.0 8.1 6.8
Glass 4.6 2.7 5.0
Jewelry 6.5 3.2 5.1
Miscellaneous 1.1 5.6 2.7
* Data of Bureau of Mines Mineral Yearbook (36).
Table 2. Platinum and palladium consumption and
their distribution among consuming industries
in the United States (1961-1972). B
Annual
average
1961-1972
Consumption of platinum
G/yr 14,274,845.38
Oz troy/yr 448,953.97
Tons/yr 15.72
Consumption of palladium 20,837,161.55
G/yr 20,837,161.55
Oz troy/yr 669,940.57
Tons/yr 22.95
Platinum consumption, % of total
noble metals use 36.7
Palladium consumption, % of total
noble metals use 53.61
Noble metal consumption, % as plati-
num and palladium 90.31
* Data from Bureau of Mines Mineral Yearbook (36).
Use of Platinum-Group Metals intheU.S.,the
Impact of Catalytic Convertors, and Their
Future Potential for Environmental Conta-
mination
Platinum, palladium, ruthenium, osmium,
rhodium, and iridium are those metals col-
lectively known as the platinum group of the
noble metals class. These metals owe their
importance to their desirable physical prop-
erties, e.g., their great resistance to most
corrosive agents. Furthermore, they have
been extensively used as catalysts in many
industrial operations. The use and distribu-
tion of platinum group metals in the United
States is presented in Table 1. The average
annual U.S. consumption was 45.7% of the
average annual world production of platinum
group metals for the period 1961 to 1972
(36). During this period, the distribution
of these metals arranged according to de-
creasing consumption among the various in-
dustries in the United States are: electrical
(43.4%), chemical (28.5%o), petroleum
(9.19), medical (6.8%), jewelry (5.1%o),
glass (5.09%), and miscellaneous (2.6%).
(Table 1). Approximately 90%o of the plati-
num group metals consumed were platinum
and palladium (Table 2).
The use of catalytic reactors for control of
motor vehicle exhaust emissions has been
considered for at least a decade (37,38).
Since then, a variety of mechanical designs
and catalytic materials have been explored
in this regard (39-41). However, the use of
platinum group metals has certain advan-
tages that preclude the use of other mate-
rials, namely: their proven effectiveness as
catalysts, low-threshold activation tempera-
tures, fast warm-up response, and apparent
Environmental Health Perspectives 42Table 3. Estimated impact of platinum demand
required for catalytic exhaust control systems
(1975-1990). a
U.S. estimated
annual Pt
demand
Average of new platinum demand for
catalyst-equipped motor vehicles
G/yr
Oz troy/yr
Tons/yr
Average new platinum demand for
converter replacement
G/yr
Oz troy/yr
Tons/yr
Total average new platinum demand
G/yr
Oz troy/yr
Tons/yr
Increase of total demand over present
consumption of platinum 2,756,832/
458,953
Increase of platinum demand corrected
for recyclingb 1,166,270/458,953
43,894,108.16
1,411,250.30
43.35
41,851,668.37
1,345,583.21
46.10
85,745,776.73
2,756,832.48
94.45
a Data of Bureau of Mines (44).
b From Table 5 (90%).
Table 4. Estimated impact of U.S. platinum demand
required for catalytic exhaust control systems
for light-duty motor vehicles
(1975-1990). a
Estimated
annual average
1975-1990
Platinum demand, g/yr 43,894,108
U.S. light-duty domestic vehicle pro-
duction and foreign car imports,
units/yr 14,112,500
Platinum requirements of each catalyst-
equipped light-duty motor vehicle,
g/unit (oz troy/unit) 3.1 (0.1)
a Data of Bureau of Mines (44). Assumes one catalyst
per car.
ability to withstand thermal stress (39,42).
The amount of platinum and palladium used
is apparently dependent in part upon me-
chanical and chemical design as well as
performance required to meet emission re-
duction requirements.
In recent Bureau of Mines reports (36,43),
the impact of this catalytic auto exhaust
abatement technology has been estimated,
and such data are summarized in Table 2.
Accordingly, the reduction of automotive
emissions by the use of catalytic convertors
will increase the demand for platinum several
times the average annual U.S. consumption
and is likely to remain the largest single use
category during the post-1975 years (Table
3) (43). Furthermore, analysis of the esti-
mated impact on U.S. platinum demands
would require doubling the present world
production. The amount of noble metals per
catalytic unit has varied in several published
reports (Table 4) (43,45-47). Analysis of
the projected demands for platinum required
for catalyst equipped light-duty motor vehi-
cles is apparently based upon a platinum
requirement of 0.10 troy oz per motor vehicle
(Table 4). The demand for platinum to sup-
ply these needs can be achieved by refining
new metals from primary sources, recycling
of platinum derived from convertor trade-ins
and scrappage of convertor-equipped auto-
mobiles. The principal source of recovery is
by convertor trade-ins (Table 5). It is impor-
tant to note that these estimates made on
future platinum demands all asume that
catalyst durability will extend over 50,000
miles of driving and apparently does not
consider the impact of new engine designs
that may alleviate requirements for these
convertors.
A platinum-palladium catalyst is composed
essentially of these noble metals thinly lay-
ered (100-200, um deep) on a bed of porous
refractory substrate material (39,48,49).
Substrates of choice appear to be a ceramic
compound of manganesium oxide, aluminum
and silicon (41,48). There have been several
substrate designs considered, namely, wire-
mesh, Raschig ring, honeycombed monolith,
and pellets (41,48). Porosity and maximum
surface area and the necessity to minimize
back pressure and to provide optimum condi-
tions for catalytic activity are important
factors influencing design selection. Pelleted
beads and a honeycombed monolith structure
are the apparent designs of choice for 1975
automobiles (48). The catalytic convertor
is located between the engine and muffler
and is protected from shock, vibration and
April 1975 43Table 5. Estimated average annual platinum recovered by various percentages of converter trade-ins and scrap-
page of catalyst-equipped motor vehicles (CEMV) from 1975 to 1990.
25% 50% 75% 90%
Average annual platinum recovered by
scrappage, g/yr 3,265,815 6,574,396 9,861,594 11,836,635
Average annual platinum recovered by con-
vertor trade-ins, g/yr a. 10,464,428 20,928,856 31,393,284 37,634,630
Estimated total platinum recycled, g/yr 13,730 2'43 27,503,252 41,254,878 49,471,265
Percentage of estimated annual average of
total platinum demand (85,745,776 g/yr),
5%0 16.1 32.1 48.1 57.7
a Data of Bureau of Mines (44).
b Convertor trade-ins assumes 50,000 mile durability and one convertor per car (44).
other external factors that influence dur-
ability by enclosure in a suitable metal hous-
ing (50). In late 1972, estimates on the use
of platinum and palladium in a 5.2 ratio was
stated to be acceptable for use in these ex-
haust convertors (43); however, this ratio
may vary with convertor design. Further-
more, alloys of platinum group metals and
base metals have been considered with the
platinum group metals being used in low
amounts to initiate the oxidation or reduc-
tion reaction (41,49). While the presently
available oxidation catalyst will employ
platinum and palladium, the material for
reduction catalysts may consist of platinum,
palladium, ruthenium, base metals or base-
metal-platinum group metal alloys (41,50).
Although the NO, reduction catalyst is still
in developmental stages, the use of platinum
group metals or other catalytic materials is
likely to produce contaminants in future
exhaust emissions unless advances are made
in combustion technology and marketable
engine designs that would negate the need
for such catalytic convertors.
Anticipated platinum losses to the environ-
ment depend in part on catalyst durability,
economic feasibility of recycling, efficiency
of the recovery process, and upon various
percentage combinations of vehicle scrappage
and converter trade-ins (50). There have
been a number of reports regarding inade-
quate durability of catalysts and the genera-
tion of catalytic attrition products from
converter-equipped automobiles (15,48,50-
55). A variety of factors can contribute to
loss of catalytic material from exhaust con-
vertor systems. Some of these include ther-
mal stress that results in sintering resulting
from melting substrate material, fuel com-
position with catalytic "poisons", fluctuations
in exhaust water content, pulsating pressure
from exhaust gases and mechanical vibra-
tions from driving conditions that can abrade
catalytic material (40,48-50). Assuming that
each car has 0.1 oz troy platinum, an analy-
sis of the estimated demand (Table 3), and
corrections made for a 90% optimal recycling
of catalytic material from scrapped auto-
mobiles and used convertor trade-ins, yield
an estimated loss of 39.67 tons of platinum
annually, i.e., 2.55 g per automobile (Tables
5 and 6). Since the reported values of plati-
num per car range from 0.005 to 0.1 oz/car,
this estimate represents the upper range.
A more realistic figure is one adjusted for
the average of the various convertor plati-
num values reported. The adjusted loss would
then be 23.31 tons of platinum, anually, or
1.49 g/car (Table 6). It is important to note
that the amount of platinum loss expressed
per light-duty motor vehicle (Table 6) is an
estimated emission value and assumes effi-
cient 90% recovery by recycling procedures.
While information regarding platinum emis-
sions from catalytic equipped automobiles is
generally not available, there is one report
that cites an emission level of 20 jug of plati-
num per vehicle mile (51). Assuming the
expected 50,000 mile durability is valid, then
the total amount of platinum lost from this
catalyst-equipped automobile would be 1 g
Environmental Health Perspectives 44Table 6. Estimated platinum emissions from catalyst-
equipped light-duty motor vehicles.
Estimated annual
average
Platinum recovered by 90%
scrappage of light-duty
motor vehicles and 90%,
convertor trade-ins (=58%
of estimated annual average
Pt demand, g/yr
Platinum loss, g/yr (tons)
Demand
Recycled
Loss
Loss per light-duty vehicle,
g/unit (36,013.226/
14,122,500)
Correction of estimated loss
from reported levels of Pt/
converter, g/unit
0.1 oz troy/converter
0.07
0.05
0.005
Average
Pt loss by emission
Pt loss per car, g/unit
Catalyst durability, miles
Calculated emission (loss/
durability), jg/mile
Reported emission, ;&g/
mile
49,732,550
85,745,776
49,732,550
36,013,226
(94.45)
(54.78)
(39.67)
2.55
2.55
1.79
1.53
0.13
1.49
1.49
50,000
30
20
a Data of Newkirk and Goluba (51).
platinum over a driving range of 50,000 miles
as compared to the above estimated value of
1.49 g/car. This value is likely to be a high
estimate for post-1975 years, depending upon
continuing progress in catalyst design and
performance that may require less platinum
per convertor unit. There is no information
available on palladium loss. However, assum-
ing a 5:2 or a 3:1 ratio of platinum to palla-
dium, the loss of palladium could range from
33 to 40% of the estimated platinum loss.
No information has been reported regarding
chemical identification of the platinum-emis-
sions. Attention should also be given to the
alumina and magnesia oxides used in sub-
strate materials which may also represent
new components of the catalyst-modified ex-
haust emission.
In addition to refractory materials asso-
ciated with catalyst supporting material,
other metallic compounds are also found in
various automotive fuels and fuel additives
(55,57). The use of tetraethyllead to in-
crease the octane level of gasoline is now
recognized as a significant threat to environ-
mental quality and to public health. The
transport pattern of lead in the atmosphere
serves as an appropriate surrogate for other
metallic exhaust emissions (34,58). Since
manganese is being considered as a fuel
additive replacement for lead and since lead
is apparently incompatable with catalytic
convertor performance, manganese is in-
cluded as an additional metallic component
expected in future exhaust emissions (35).
The compatability of manganese and other
fuel additives with convertor performance
and their influence upon the nature of ex-
haust emissions remains to be determined.
Occupational Hazards of Platinum and Palla-
dium
The principal health adversities resulting
from exposure to platinum group metals are
respiratory and cutaneous hypersensitivities
associated with complex salts of platinum
and their aqueous solutions (59-63). Platino-
sis is defined as an allergic reaction following
exposure to soluble platinum salts which
elicits a progressively more pronounced asth-
matic response uponcontinued exposure (60).
Immediate allergic hypersensitivity to plati-
num salts apparently results from induced
histamine release elicited by exposure to
hexachloroplatinate intermediates in plati-
num refining operations (62-64). There have
been no industrial hygiene problems asso-
ciated with palladium.
Classical allergic symptoms are displayed
in platinosis with occasional severe anaphy-
laxes observed among sensitive or sensitized
individuals. Individuals that are not initially
sensitive may work in the presence of these
allergins for years without noticeable adver-
sities, however, the majority become sympto-
matic upon continued exposure (60). The
platinosis syndrome consists of sneezing,
rhinorrhea, tightness of chest, shortness of
breath, cyanosis with contact urticaria,
wheezing and cough that resembles a mix-
April 1975 45ture of hay fever and asthma. Once disabling
symptoms appear in any one case that in-
dividual will never again become asympto-
matic in an atmosphere containing soluble
salts of platinum unless desensitized by
hyposensitization procedures (60). Hyposen-
sitization has been reported in one individual
by intradermal injections of ammonium hexa-
chloroplatinate administered several times
daily over a 30-day period (65). While this
form of treatment was accompanied by a
serum sickness-like reaction, it was deemed
successful since subsequent exposure to solu-
ble platinum salts proved uneventful.
Progression of the platinosis syndrome is
accompanied by varying degrees of irrita-
tion of the upper respiratory tract, conjunc-
tivae and mucous membranes with hyper-
trophy of lymphatic tissues and a mild lym-
phocytosis (59-63). The mechanisms pro-
posed for the activity of these compounds
involves platinum salts presumably acting
as a hapten as a result of combining with
serum albumin to form an allergenic hapten-
protein complex (66). The immediate hyper-
sensitive reaction may be specific for specific
platinum ions. In vivo and in vitro experi-
mental studies have described the influence
of hexachloroplatinate on cilia activity in
guinea pigs and notes the release of his-
tamine is restricted to platinic ion of coordin-
ation number six (64). A differentiation of
the disease into a major form that includes
asthma, cutaneous eczema, and urticaria and
a minor form with rhinopharyngitis, cough,
dyspnea, itching, and conjuctival vasodilation
has been proposed. However, while varia-
tions occur with symptomology that include
features from both forms, the immunological-
allergic mechanisms of immediate and de-
layed hypersensitivity underlie both response
modes.
Eczematous dermatitis and allergic contact
sensitivity notes a delayed hypersensitive re-
sponse differing in mechanism from immedi-
ate allergic response. Dermal manifestation
may be acute with urticaria, itching in ex-
posed areas, subacute in which a typical
contact dermatitis is observed and chronic
with secondary eczema and persistent con-
tact dermatitis (67). Dermal reactions to
platinum can be particularly dramatic, with
dermatosis observed beneath clothing of a
sensitive individual with a pocket containing
a handkerchief contaminated with platinum
salts (2). One industrial hygiene survey car-
ried out over a 5-yr period reports that in-
dividuals with red hair, moles, freckles and
a history of skin irritation are those that
appear to be particularly sensitive to soluble
salts of platinum (60). It is to be noted that
these compounds are largely insoluble in dis-
tilled water with solubility improved in
normal physiological saline (63). In this
regard, absorption is feasible via dermal and
pulmonary exposure routes (68). Normal
perspiration and fluids present in the lungs
may solubilize insoluble compounds and per-
mit absorption into the body (69,70).
There has been only one report in which
health adversities were examined, prevalence
of platinosis recorded, and industrial atmos-
pheric platinum levels determined (59). At-
mospheric measurements in four platinum
refineries that involved 114 employees ranged
from 0.9 to 1700 Ug/m3. The prevalence of
symptomatic individuals among the 91 em-
ployees examined was 71%, with 57% suf-
fering from asthmatic response and appar-
ently 14%o presenting dermatological prob-
lems. The number of individuals with both
involvements was not reported. The authors
note the severity and intensity of response
was highest among those individuals em-
ployed in crushing platinum salts and ex-
posed to levels of atmospheric platinum
ranging from 400 to 1700 pg/m3' However,
analysis of the data presented suggests that
exposure risk is apparently equivalent in
platinum atmospheres associated with both
wet and dry refining procedures. Further-
more, there does not appear to be a definite
dose-response relationship (Table 7). Data
from other refineries in this report are in-
adequate for comparative purposes since
distinction between wet and dry operations
are not clearly defined. It is noteworthy that
in one refinery equipped with a ventilation
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refineries. a
Exposure
Spray Dust
aerosols wet dry
operations operations
Refinery A
Range of atmospheric
Pt, jAg/m3 7 -20 400 -1,700
No. of employees 18 6
Employees with asthma 6 5
Employees with
dermatitis 1
Refinery B
Range of atmospheric
Pt,,ug/m3 1.6- 6.9 4.1- 50.2
No. of employees 29 46
Employees with asthma 14 16
Employees with
dermatitis 3 5
Total, Refineries A and B
-No. of employees 47 52
Employees with asthma 20 21
Employees with
dermatitis 4 5
* Data of Hunter et al. (59).
system, the atmospheric platinum levels
ranged from 0.9 to 3.2 /Ug/m3. Mild symptoms
of running nose and sneezing were reported
in five of the seven individuals in this refinery
when they were exposed to spray aerosols of
platinum salts. While the current threshold
limit value is presently 2.0 fAg/m3 for soluble
platinum salts, initiation of response appar-
ently occurs between 0.19 and 3.2 fAg/m3. In
the later 5-yr refinery survey without aero-
metric measurements, symptomology was re-
ported to be 100% with 60% of the employees
affected with the major asthmatic form and
40% with the minor dermatological form of
platinosis (60). A third survey reports a
65% prevalence (62). The latency period
prior to the appearance of platinosis symp-
tomology ranges from months to a maximum
of 10 yr (62). The 5-yr study is perhaps the
best index to incidence over a prolonged
period and particularly relevant to environ-
mental considerations.
A variety of chemicals have induced
allergic reactions and have posed occupa-
tional problems, namely; penicilin, strepto-
mycin, chloropromazine, aromatic amines,
Table 8. Allergic or irritant reaction of
selected metals. a
Metalb Allergic/irritant reactionc TLV,
mg/M3 d
Barium Dermal, nasal 0.5
Cobalt Asthma, dermal 0.5
Chromium Dermal, upper respiratory 0.1
Copper Dermal 0.1
Gallium Dermal
Mercury Dermal 0.1
Nickel Dermal
Platinum Asthma, dermal 0.002
Thallium Dermal 0.1
Tin Dermal 0.1
Vanadium Asthma, dermal 0.5
a Data of Stokinger (67).
b Each metal class includes metallic compounds with
a wide variety of anions and organic analogs.
e Reactions were selected only from industrial hy-
giene observations.
d Data of American Conference of Industrial Hy-
gienists (18).
chlorinated ethylene derivatives, and tolu-
lene diisocyanates (62,71). However, the
potency of the sensitizing capacity of soluble
salts of platinum is evident among the thres-
hold limit values established for other metals
that have an occupational history of allergic
response (Table 8). The threshold limit value
(TLV) of soluble platinum salts is 100
times lower than those for other metals
that have associated asthmatic conditions
reported with exposure. It is important to
recall the limitations placed on the use of
threshold limit values. Appropriate compari-
sons of the various metals listed with aller-
genic properties requires careful inspection
of the data base used to establish the thres-
hold limit values. Nevertheless, these values
do not assure protection for sensitive or
sensitized individuals. Therefore, soluble
salts of platinum compounds may contribute
to levels of existing airborne allergens in
the ambient air with potential aggravation
of individuals with preexisting asthmatic or
cardiorespiratory deficiencies. Approximately
3-5% of the population in the United States
are asthmatics, and this represents a rather
large susceptable subgroup (6-10 million
people) (9). Furthermore, these compounds
April 1975 47Table 9. Estimated short-term exposures to platinum emissions from catalytic equipped vehicles under various
meteorological conditions with a dispersion model. ^
Exposure levels, sg/rmn
Exposure Normal meteorological Adverse meteorological
Receptor location conditions b conditions b
Wind directly Wind at Wind directly Wind at
across worst across worst
highway angle highway angle
Lead levels
Automobile passengers
Pedestrians
Expressway (from lead
measurements) c
Near expressway (from
22-28 39 120 690
lead measurements) e 17-39 28 110 490
Estimated platinum levels, 25% of light-duty motor vehicles equipped with catalytic convertors (1976)
Automobile passengers Expressway 0.001 0.003 0.009 0.05
Pedestrians Near expressway 0.001 0.002 0.008 0.03
Estimated platinum levels, 100% of light-duty motor vehicles equipped with catalytic convertors (1982)
Automobile passengers Expressway 0.004 0.012 0.04 0.20
Pedestrians Near expressway 0.004 0.008 0.03 0.12
a Prepared from: Estimated changes in human exposure to suspended sulfate attributable to equipping
light duty motor vehicles with oxidation catalyst (unpublished NERC/RTP working document).
b Data of D. B. Lurner, and L. Niemeyer, Meteorology Laboratory, National Environmental Research
Center, Research Triangle Park, N.C., personal communication.
Data of National Academy of Sciences Report (58).
Computed by multiplying sulfate levels by adjustments for digerences in emissions per vehicle-mile:
(0.00002 ug/mile Pt/(0.05 ug/mile sulfate).
may prove to be additive or synergistic with
co-exposure to other ambient air pollutants.
Warnings regarding potential hypersensitive
reactions to platinum compounds used thera-
peutically as anticancer agents have been
published (69). While the amount of plati-
num used for medical purposes is small
compared to its other uses (Table 1), should
the therapeutic use of platinum increase,
those individuals undergoing treatment
would also need to be considered in evaluating
exposure risks to allergenic platinum salts
in the ambient air.
Exposure Estimates
At the present time, platinosis has been
primarily an occupational hazard. The use,
distribution, and value of platinum and other
noble metals has restricted their appearance
as environmental contaminants. Evidence in
support of this conclusion is found in the
low levels of platinum observed in prelimi-
nary residue analysis of human tissues from
autopsy material (72).
Although extensive trace metal analysis
of catalytic modified exhausts are not avail-
able, estimates of short-term platinum ex-
posure levels for a dispersion model range
from 0.001 to 0.1% of the threshold limit
value for soluble platinum salts, i.e., 0.002-
0.2 ,Fg/m3 (Table 9). Lead estimates are made
assuming a lead emission of 0.07 grams per
vehicle mile. The estimated lead levels (16
to 41 'Ug/m3) are close to actual measure-
ments (4.5 to 71.3 ,g/m3) made under typical
meteorological conditions near the Los
Angeles freeway (58). The actual values
may be lower than estimated as a conse-
quence of lead settling near the roadside.
Conversely, underestimations are possible
as a result of actual recirculation of settled
emission particulate matter by the traffic
stream not considered in the model. Platinum
exposure levels were estimated using the
reported emission value of 0.0002 g/mile
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products are in emission particulate matter
similar to that of lead (14,51,55). It is to
be recognized that gaseous platinum oxides
may form and the emission level reported
may represent a low value. Conversely, the
catalyst used may have been faulty and
the reported value an upper boundary. Esti-
mates were made by using adjustments for
the lower platinum emission level and the
percentage of light-duty motor vehicles
equipped with catalytic convertors, i.e., lead
values X 0.00002 1g/mile Pt . 0.07 jug/mile
Pb X 0.25 = lead values X 7.14 X 10-5. All
of the platinum estimates are 1976 and 1982
projections when 25 and 100% of the na-
tional light duty motor vehicle fleet would
be equipped with catalytic convertors.
In order to evaluate these estimates of
platinum levels in the ambient air, consid-
eration must be given to the nature and
potency of the expected allergic response, the
threshold limit values (2.0 jug/m3), and re-
finery range observed that produced mild
symptoms under ventilated conditions (0.19-
3.1 /Ug/m3). It is not unlikely that platinum
sensitization could occur and sensitive in-
dividuals react upon continuous short-term
exposures (automobile passengers, pedes-
trians) to estimated levels that may appear
under worst meteorological conditions with
25% of the light-duty vehicles equipped with
catalysts. The response probability increases
considerably when all light-duty motor ve-
hicles are equipped with catalysts since the
estimated ambient air platinum levels are
0.1%o of the threshold limit value under
worst meteorological conditions. Considera-
tion must also be given to exposure risks of
urban residents living near busy arterial
freeways and subjected to these levels con-
tinuously. Furthermore, average hourly peak
levels may reach and exceed the threshold
limit value under adverse weather conditions
in urban areas. It is important to interpret
estimated projections cautiously, since the
projections are only as valid as the assump-
tions made. The major significant conclusion
from these estimates is that a new environ-
mental agent can be expected in the ambient
air at detectable levels by 1976.
The Genesis Problem
The catalytic attrition material identified
to date in exhausts from convertor equipped
automobiles has been primarily associated
with particulate matter (51). Toxicity de-
pends both upon the chemicaf and physical
properties of the particulate matter. Particle
size and mass are fundamental in determin-
ing residence time in the atmosphere, pul-
monary distribution and dosage (14,73,74).
In addition to inorganic material (halides,
sulfur, phosphorus), polycyclic organic ma-
terial and trace metals are associated with
automotive particulate emissions, some of
which have been linked with the incidence
of lung cancer (18,56,75-77). Although the
quality and quantity of air pollution may
vary from city to city, there appears to be
sufficient evidence to confirm an urban fac-
tor in etiology of lung cancer. It is important
to realize that carcinogenicity and the onset
and progression of other chronic degenera-
tive diseases can be modified by physiological
predisposition, occupational differences, and
social-personal health habits (smoking).
However, the etiological role of air pollu-
tion in human lung cancer has been con-
vincingly demonstrated by epidemiological
methods. In comparing lung cancer rates in
migrants to rates in their country of origin
and the country to which they emigrated it
was concluded that differences in death rates
are compatible with the changes in their
environment and general pollution level (78).
Furthermore, individuals in the U.S. who
move from high pollution to low pollution
regions display reduced lung cancer rates,
indicating a definite risk-gradient from
rural-low to urban-high air pollution areas
(7,79). It is important to realize that corre-
lations between residence and lung cancer
persist even following corrections made for
cigarette smoking (7).
Urban air and cigarette smoke have car-
cinogenic chemical agents in common that
April 1975 49are present in the benzene-soluble fraction
of airborne particulate matter (6,7,10,14,
33,80). The level of polynuclear aromatic
hydrocarbons (PNA) in ambient air is in-
dexed by measuring the benzo[a]pyrene
(BaP) content (14). While whole PNA
samples and BaP have proven to be carcino-
genic by various bioassays, it is important
to recognize that not all chemical carcino-
gens have been identified, and the role of
polycyclic aromatic hydrocarbons or BaP as
human carcinogens has yet to be confirmed
(14,80). Furthermore, other unregulated
ambient air pollutants, such as sulfur dioxide,
ferric oxide, and chromium, have been shown
experimentally to exert a potentiating effect
on the carcinogenic properties of polycyclic
aromatic hydrocarbons (76,81,82). Sulfur
dioxide has not only been shown to poten-
tiate the carcinogenicity of benzo[a]pyrene
in rats but the tumors observed are morpho-
logically similar to those observed in man
(11). Although arguments are raised re-
garding the relevance of experimental ani-
mal data to man and threshold limits for
carcinogenicity, sufficient epidemiological
and experimental data exist that document
a definite risk associated with exposure to
carcinogenic and cocarcinogenic agents in
the urban ambient air (7,14,83). It is im-
portant to recall that reduction of hydro-
carbons in compliance with the statuatory
requirements of the Clean Air Act is im-
portant in regulating photochemical oxidants
and is to be distinguished from control of
nonmethane carcinogenic hydrocarbons as-
sociated with particulate emissions. Accord-
ingly, reductions in carcinogens (benzo[a]-
pyrene) and cocarcinogens (metallic ligands)
associated with particulate matter could be
achieved by regulating particulate emissions.
The question remains as to the potential car-
cinogenicity and cocarcinogenicity of plati-
num and palladium.
While trace metals may serve as cocar-
cinogens, the interaction of platinum and
palladium with the reticuloendothial systems
and modification of immunodefense mechan-
isms is of particular interest regarding con-
tributions to the carcinogenic potential of
polluted ambient air (14). A lifetime feeding
study that involved administering 5.0 ppm
of palladium chloride to mice in their drink-
ing water significantly and selectively in-
creased the malignant tumor incidence and
increased the longevity of male mice (84).
While the tumor incidence may reflect the
difference in longevity, most of the tumors
observed were of the lymphoma-leukemia
types (controls: 2, palladium: 10). Adeno-
carcinoma or pappilary adenocarcinoma of
the lungs were the second most prevalent
tumors observed (controls: 1; palladium: 6).
Apart from their role as possible cocarcino-
gens, there is an interesting apparent corre-
lation between the capacity of several trace
metals to induce contact dermatitis and their
association with human carcinogenicity, spe-
cific reference is made to nickel and chro-
mium (67). There is one report that indicates
exposure to palladium can induce contact
dermatitis (85). As noted previously, ex-
posure to soluble platinum salts involves
hypertrophy of lymphoid tissues and lympho-
cytosis.
The theories pertaining to carcinogenic
mechanisms are varied. However, in view of
the biological activity of platinum and palla-
dium attention is referred to the role of the
immunoresponse system in chemical carcino-
genicity (14). Tumor specific antigens are
present in most neoplasms with early stages
of onset marked by extensive lymphocytic
infiltration (86-88). While the significance
of tumor antigens in carcinogenesis remains
unexplained, the involvement of these noble
metals with immediate and delayed hyper-
sensitivity, their capacity to alter lymphatic
tissue, to bind with DNA and proteins all
serve as a reason for concern regarding inter-
ference in immunosurveillance mechanisms
involved in the carcinogenic process. Addi-
tional concerns regarding the biological ac-
tivity of platinum and palladium are focused
upon the rather short latent period for induc-
tion of maligencies arising from disturbances
in the reticuloendothelial system and the mu-
tational potential of these noble metals (89).
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agents that reach bone-marrow tissues, tra-
verse the placental barrier, and interact with
genetic material have a potential to be muta-
tagenic and teratogenic as well as carcino-
genic. Evidence of transplacental passage of
palladium will be presented at this confer-
ence (90). Nearly all malignant and many
benign neoplasia are characterized by dis-
torted chromosomal karyotypes (27-29,31,
91,92). The clastogenic properties of several
metals and metallic ligands are recognized
and it is important to realize that these
events often occur in the absence of cellular
lethality, reflect interaction with DNA and
distortions in those mechanisms responsible
for accurate cellular genetic repair (27,93).
In accord with central dogma of gene expres-
sion (27), the appearance of tumor-specific
antigens provides evidence in support of
mutational theories of carcinogenicity or
epigenetic alterations in mechanisms govern-
ing gene expression transferred through cy-
toplasmic inheritance.
Hereditary disease has become a growing
concern and can result in expansion of sus-
ceptible subgroups in the population with a
resultant increase in medicare costs (2,94).
Approximately 250,000 genetically abnormal
children are born in this country each year
with defects ranging from chromosomal ab-
normalities (trisomy and mongolism) to
subtle inborn errors of metabolism (enzy-
matic defects) requiring clinical treatment,
e.g. Lesch-Nyhan syndrome. There are ap-
proximately 1876 medical conditions attrib-
uted to genetic effects that account for 259
of all infant fatalities and a similar per-
centage of hospitalized adults (83,95). It
has been estimated that each individual
carries between 5 and 10 genetically harmful
genes (34,37). Since approximately all human
carcinogens, are induced by environmental
chemicals, and since most mutagens are
likely to be carcinogens, attention should be
given to adequate analysis of their mutational
potential by evaluating distortions in bio-
equivalent molecular mechanisms governing
these genetic lesions of both somatic and
germinal tissues (96,97). We will learn in
subsequent papers to be presented (70,90,98),
that platinum and palladium can be absorbed
by inhalation, dermal, and oral exposure
routes (90,98). In this regard, the chemical
identity of platinum-group metals in exhaust
emissions and their metabolic ligands are
critical to the environmental impact analysis
of these expected new contaminants.
Biotransformation
It can be anticipated that noble metals
associated with the use of catalytic con-
verters will not only be emitted into the air
but will also deposit on the ground. Accumu-
lation of platinum and palladium in streams,
rivers, lakes, and their sediments can result
from discarded catalytic materials as well
as from ground water contamination by ex-
haust attrition products from rain-washed
highways. While effects on microbiological
flora and plant life are of ecological concern,
microbial biomodification in stream and lake
sediments is of specific interest, since this
may serve to modify toxicity and promote
food chain contamination. The environmental
impact and public health consequences aris-
ing from mercury contamination in the food
chain has been well defined (19, 20, 99). The
disasters of Minamata and Niigata, Japan,
serve to underscore the toxicological signifi-
cance of environmental biomodifications. Al-
though a variety of mercury compounds have
been involved, the etiological agent identified
in Minamata and fetal Minamata disease is
methylmercury (19,20,99). The stability of
the alkyl-mercury bond in biological systems
determines its capacity to traverse the blood-
brain barrier with irreversible neurological
damage, to-cross the placenta and accumulate
in fetal tissues with dire teratological con-
sequences, and to contaminate and accumu-
late with increasing concentrations in the
food chain.
The transformation of mercury compounds
into methylmercury occurs via a bioequiva-
lent reaction common to microbes, plants and
animals and involves methylcorrinoid deriva-
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Platinum compounds have recently been
shown to interfere with methylation chem-
istry essential to vitamin B12 metabolism
(100). Apart from methyl group transfer to
the metal involved, this interference can
impose disturbances in the oxidation of odd-
carbon fatty acids and the biosynthesis of
essential amino acids (101). In addition to
mercury, there have been recent reports in-
dicating that thallium, gold, and platinum
can be methylated by this common methyl-
cobalamin (vitamin B12) reaction (20,102).
While these reports need to be confirmed, the
bioenvironmental significance will depend
upon the stability of the methylated platinum
compounds and level of environmental con-
tamination of these methylation products.
With experimental animal models of Mina-
mata disease, the biological response to
methylmercury appears to be the result of
a disturbance in protein synthesis associated
with the endoplasmic reticulum (103-107).
Alterations in serum protein level were noted
prior to the appearance of neurological signs
of poisoning (105). These experimental ob-
servations appear to have been clinically
confirmed, since many of the Japanese vic-
tims of methylmercury poisoning displayed
changes in serum protein levels (108). It is
noteworthy, that preliminary results indi-
cate that an alteration in serum protein levels
appears to be a significant response observed
among experimental animals exposed to cata-
lyst modified exhaust emissions containing
an estimated 0.029 /Lg/m3 of platinum (60).
Preliminary analysis of platinum and palla-
dium residues among organs of experimental
animals treated by various exposure routes
(oral, intraperitoneal injections, inhalation)
indicates the kidneys and liver have higher
levels of these metals than other organs of
the body (79,90,98). A similar pattern was
observed in methylmercury-treated animals.
Neurological signs of intoxication appear as
a function of the amount present in the
brain (99,103). While pollutant burden
analyses are useful exposure indicators,
organ redistribution and metabolic transfor-
mation tends to limit their capacity in pre-
dicting impending pathology.
In order appropriately to assess potential
health hazards associated with the possible
biotransformation of platinum and palla-
dium further information is required, par-
ticularly regarding the stoichiometry and
kinetics of their methylation chemistry as
well as evidence that stable methylated com-
pounds are of significant toxicity. In this
way quantitative estimates regarding trans-
fer and transport processes in vivo and in
ecological systems can be approached with
a reasonable degree of confidence.
Comment
There is insufficient quantitative infor-
mation available adequately to assess the
environmental toxicology of platinum and
palladium. These agents are expected to
reach detectable levels in the ambient air by
1976, when 25% of the light-duty motor
vehicles will be equipped with catalytic con-
vertors. Continued use of catalytic convertors
over an ensueing 6-yr period yields estimates
of platinum in the ambient air under adverse
weather conditions close to the threshold
limit value set for soluble platinum salts.
Individuals sensitive or sensitized to plati-
num may react immediately, depending on
the level and chemical nature of soluble
platinum salts that may be present in exhaust
emissions. Since an average latent period of
platinoisis is approximately 5 yr, with due
consideration given to available information,
it would not be unreasonable to expect an
increase in asthma and contact dermatitis
with continued use of these emission control
devices beyond 1982. In this 8-yr period when
all of the light-duty motor vehicles in the
United States would be equipped with cata-
lytic convertors, an estimated 164 tons of
platinum would have been lost to the environ-
ment. This may represent an upper range de-
pending on catalyst durability and recycling
efficiency. It is important to realize that a
large percentage of the automobiles are
located in urban areas. The time in which
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in drinking water or the amount required for
potential microbial methylation cannot be
determined at this point.
In the absence of adequate information
for impact analysis, the areas of concern
have been identified and investigations under-
taken. Preliminary results will be presented
and include the following highlights. Plati-
num and palladium can be absorbed into
biological tissues when administered to ex-
perimental animals by various exposure
routes (72,90,98); soluble platinum com-
pounds (Pt+4) are more toxic than com-
pounds of other metals of interest (Mn, Pb)
when administered orally; however palla-
dium is more toxic than these metals when
administered intravenously (98). Absorbed
noble metals can traverse the placental bar-
rier in pregnant experimental animals (90).
Preliminary cardiovascular studies suggest
that palladium can act as a nonspecific car-
diac irritant as well as a peripheral vasocon-
strictor in experimental animals (90). At the
present time, there is relatively little con-
tamination of platinum in human tissues
(72).
It is important to recall the low concen-
trations required for immunological and
allergic response. While sulfuric acid aero-
sols and particulate sulfates may adversely
affect existing asthmatics, they are not con-
sidered allergenic in the same context as
soluble salts of platinum, i.e., these platinum
compounds have the capacity to induce
asthma as well as aggravate existing asth-
matic conditions. Furthermore, reducing sul-
fur emission products may be alleviated by
reducing the sulfur content in gasoline. Regu-
lation of noble metals attrition products
would require discontinued use of catalytic
convertors in the concurrent advancements
in engine design in order to still comply with
statutory standards (CO, HC, NO.-), the use
of alternate convertor designs with high
durability (41), or any future legislative
constraints on particulate exhaust emissions.
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